Please provide your email address to receive an email when new articles are posted on . The Freestyle Libre 2 and 3 CGM sensors are now approved to be worn during imaging procedures. A system ...
With a single sensor, the Eversense 365 system provides one year of use, versus 10-14 days with short-term CGM’s for minimal life disruption “Managing diabetes can be stressful and it is important for ...
Ultra-low-power TMR switches enable reliable CGM activation by minimizing energy consumption while maintaining accurate, responsive device performance.
Diabetes remains one of the nation’s most prevalent and dangerous chronic conditions, affecting nearly 15% of U.S. adults and causing more than 100,000 deaths each year. As a response, the landscape ...
GERMANTOWN, Md., Jan. 29, 2026 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NASDAQ: SENS) a medical technology company focused on the development and manufacturing of long-term, implantable ...
DexCom, Inc. DXCM recently unveiled new data for its upcoming G7 15-day continuous glucose monitoring (CGM) sensor at the Advanced Technologies & Treatments for Diabetes (ATTD) conference 2025. With ...
DUBLIN, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable ...
This morning Belgian startup Indigo Diabetes announced a €38 million ($44.6 million) Series B funding round. This round included contributions from new investors Fund+, Ackermans&van Haaren, Capricorn ...
Continuous glucose monitoring (CGM)-derived metrics reliably identified cystic fibrosis-related diabetes in patients with cystic fibrosis. Additionally, a novel way of analysing CGM data called ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results